Treatment of Diabetes and Osteoporosis—A Reciprocal Risk?
Diabetes mellitus is a metabolic and systematic disorder that requires individualized therapy. The disease leads to various consequences, resulting in the destruction of tissues and organs. The aforementioned outcomes also include bone mineral disorders, caused by medications as well as diet therapy...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/10/9/2191 |
| _version_ | 1797490908410675200 |
|---|---|
| author | Agnieszka Zawada Alicja Ewa Ratajczak Anna Maria Rychter Aleksandra Szymczak-Tomczak Agnieszka Dobrowolska Iwona Krela-Kaźmierczak |
| author_facet | Agnieszka Zawada Alicja Ewa Ratajczak Anna Maria Rychter Aleksandra Szymczak-Tomczak Agnieszka Dobrowolska Iwona Krela-Kaźmierczak |
| author_sort | Agnieszka Zawada |
| collection | DOAJ |
| description | Diabetes mellitus is a metabolic and systematic disorder that requires individualized therapy. The disease leads to various consequences, resulting in the destruction of tissues and organs. The aforementioned outcomes also include bone mineral disorders, caused by medications as well as diet therapy and physical activity. Some drugs may have a beneficial effect on both bone mineral density and the risk of fractures. Nevertheless, the impact of other medications remains unknown. Focusing on pharmacotherapy in diabetes may prevent bone mineral disorders and influence both the treatment and quality of life in patients suffering from diabetes mellitus. On the other hand, anti-osteoporosis drugs, such as antiresorptive or anabolic drugs, as well as drugs with a mixed mechanism of action, may affect carbohydrate metabolism, particularly in patients with diabetes. Therefore, the treatment of diabetes as well as osteoporosis prevention are vital for this group of patients. |
| first_indexed | 2024-03-10T00:39:47Z |
| format | Article |
| id | doaj.art-efe92899eee349ceb0152cddc668dcd2 |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-10T00:39:47Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-efe92899eee349ceb0152cddc668dcd22023-11-23T15:10:39ZengMDPI AGBiomedicines2227-90592022-09-01109219110.3390/biomedicines10092191Treatment of Diabetes and Osteoporosis—A Reciprocal Risk?Agnieszka Zawada0Alicja Ewa Ratajczak1Anna Maria Rychter2Aleksandra Szymczak-Tomczak3Agnieszka Dobrowolska4Iwona Krela-Kaźmierczak5Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznn, PolandDepartment of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznn, PolandDepartment of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznn, PolandDepartment of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznn, PolandDepartment of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznn, PolandDepartment of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznn, PolandDiabetes mellitus is a metabolic and systematic disorder that requires individualized therapy. The disease leads to various consequences, resulting in the destruction of tissues and organs. The aforementioned outcomes also include bone mineral disorders, caused by medications as well as diet therapy and physical activity. Some drugs may have a beneficial effect on both bone mineral density and the risk of fractures. Nevertheless, the impact of other medications remains unknown. Focusing on pharmacotherapy in diabetes may prevent bone mineral disorders and influence both the treatment and quality of life in patients suffering from diabetes mellitus. On the other hand, anti-osteoporosis drugs, such as antiresorptive or anabolic drugs, as well as drugs with a mixed mechanism of action, may affect carbohydrate metabolism, particularly in patients with diabetes. Therefore, the treatment of diabetes as well as osteoporosis prevention are vital for this group of patients.https://www.mdpi.com/2227-9059/10/9/2191antihyperglycemic agentsdiabetesosteoporosisdiet |
| spellingShingle | Agnieszka Zawada Alicja Ewa Ratajczak Anna Maria Rychter Aleksandra Szymczak-Tomczak Agnieszka Dobrowolska Iwona Krela-Kaźmierczak Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? Biomedicines antihyperglycemic agents diabetes osteoporosis diet |
| title | Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? |
| title_full | Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? |
| title_fullStr | Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? |
| title_full_unstemmed | Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? |
| title_short | Treatment of Diabetes and Osteoporosis—A Reciprocal Risk? |
| title_sort | treatment of diabetes and osteoporosis a reciprocal risk |
| topic | antihyperglycemic agents diabetes osteoporosis diet |
| url | https://www.mdpi.com/2227-9059/10/9/2191 |
| work_keys_str_mv | AT agnieszkazawada treatmentofdiabetesandosteoporosisareciprocalrisk AT alicjaewaratajczak treatmentofdiabetesandosteoporosisareciprocalrisk AT annamariarychter treatmentofdiabetesandosteoporosisareciprocalrisk AT aleksandraszymczaktomczak treatmentofdiabetesandosteoporosisareciprocalrisk AT agnieszkadobrowolska treatmentofdiabetesandosteoporosisareciprocalrisk AT iwonakrelakazmierczak treatmentofdiabetesandosteoporosisareciprocalrisk |